In a landmark development for the field of neurology, pharmaceutical firm Arrowhead Pharmaceuticals has achieved a milestone...
The American Association of Pharmaceutical Scientists (AAPS), a global non-profit organization representing more than 7,000 scientists and...
NEW YORK, NY — As October marks Breast Cancer Awareness Month, the familiar landscape of pink ribbons...
Jordan’s Role as a Global Humanitarian Beacon: WHO Director-General Concludes High-Level State Visit
Jordan’s Role as a Global Humanitarian Beacon: WHO Director-General Concludes High-Level State Visit
AMMAN, Jordan – The World Health Organization (WHO) Director-General, Dr. Tedros Adhanom Ghebreyesus, has completed the first...
Metastatic breast cancer (mBC)—clinically classified as Stage IV breast cancer—represents the most advanced form of the disease....
Oklahoma City, OK – In a significant breakthrough that could reshape our understanding and treatment of aggressive...
London, UK – In a significant move to modernize its regulatory framework and accelerate patient access to...
An In-depth Examination of Emerging Research and Patient Considerations By Douglas Feil, NBCF Chief Program Officer In...
NEW YORK, NY — On the evening of October 13, 2026, the global skyline will undergo a...
De-Escalating Treatment: The CompassHER2-pCR Trial and the Future of Personalized Breast Cancer Care
De-Escalating Treatment: The CompassHER2-pCR Trial and the Future of Personalized Breast Cancer Care
The landscape of oncology is currently undergoing a seismic shift, moving away from the "one-size-fits-all" approach toward...
